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Abstract
Background: This study will test the uptake and effectiveness of a flexible package of smoking cessation support
provided primarily by the practice nurse (PN) and tailored to meet the needs of a diversity of patients.
Methods/Design: This study is a cluster randomised trial, with practices allocated to one of three groups 1) Quit
with Practice Nurse 2) Quitline referral 3) GP usual care. PNs from practices randomised to the intervention group
will receive a training course in smoking cessation followed by access to mentoring. GPs from practices
randomised to the Quitline referral group will receive information about the study and the process of written
referral and GPs in the usual care group will receive information about the study. Eligible patients are those aged
18 and over presenting to their GP who are daily or weekly smokers and who are able to give informed consent.
Patients on low incomes in all three groups will be able to access free nicotine patches.
Primary outcomes are sustained abstinence and point prevalence abstinence at the three month and 12 month
follow-up points; and incremental cost effectiveness ratios at 12 months. Process evaluation on the reach and
acceptability of the intervention approached will be collected through Computer Assisted Telephone Interviews
(CATI) with patients and semi-structured interviews with PNs and GPs.
The primary analysis will be by intention to treat. Cessation outcomes will be compared between the three arms at
three months and 12 month follow-up using multiple logistic regression. The incremental cost effectiveness ratios
will be estimated for the 12 month quit rate for the intervention groups compared to usual care and to each
other. Analysis of qualitative data on process outcomes will be based on thematic analysis.
Discussion: High quality evidence on effectiveness of practice nurse interventions is needed to inform health
policy on development of practice nurse roles. If effective, flexible support from the PN in partnership with the GP
and the Quitline could become the preferred model for providing smoking cessation advice in Australian general
practice.
Trial Registration: ACTRN12609001040257
Background
Tobacco remains the most common preventable cause
of death in the world today. The World Health Organi-
zation estimates that tobacco killed 5.4 million people
globally in 2008 and on current trend this will rise to 8
million deaths per year by 2030 with more than 80% of
deaths occurring in the developing world [1]. Despite
reduction in prevalence of smoking in the Australian
population, tobacco use and dependence remains the
risk factors associated with the greatest disease burden,
accounting for 9.5% of the total burden in men and 6%
in women [2]. More than one in six Australians con-
tinue to smoke each day, and tobacco smoking is
responsible for the premature deaths of about 16,000
Australians each year [3]. Less than 10% of Australian
smokers consistently deny any interest in quitting and
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approximately 40% report attempting to quit in the pre-
vious year [4]. Unfortunately unaided quit attempts have
a low success rate of only 3-5% [5].
Suitability of general practice for a quit smoking
intervention
General practice is well suited for supporting smoking
cessation. Around 85% of the Australian population vis-
its a general practitioner (GP) at least once a year [6].
There is variation in reported rates of smokers present-
ing in general practice, with between 19.9% -35% of
adult patients reported as currently smoking [7,8]. The
familiar environment of general practice and the sus-
tained relationships between patients and providers can
provide an environment conducive to effective promo-
tion of behavioural risk factor modification [9].
Current general practice intervention
There is clear evidence that smoking cessation advice
from a physician has an effect. The Cochrane review of
17 trials of brief advice versus no advice estimates that
brief advice increases absolute rates of cessation at one
year follow-up by about 2.5% compared to usual care
[10]. This effect can be increased substantially if brief
advice is combined with other evidence based support
such as pharmacotherapy [11].
GPs in Australia as elsewhere have been encouraged
by clinical practice guidelines [11] to offer smoking ces-
sation advice and support, and some have attended
training [12]. Despite this the number of patients who
report receiving advice on smoking cessation from GPs
is low [13]. In an Australian study of GPs’ use of evi-
dence-based approaches only 32% provided written
materials and 28% set a ‘quit date’ [14]. Barriers raised
by GPs to engaging in greater efforts in smoking cessa-
tion include: perception of lack of effect; lack of GP
time; lack of GP skills; reluctance to raise the issue due
to perceived patient sensitivity about smoking; and per-
ceived lack of patient motivation [15].
Quitline referral
An alternative to in-practice support from the GP is for
GPs to identify smokers, provide brief advice and
actively refer interested patients to the telephone Quit-
line. A study in Australia which compared standard in-
practice management to this active referral to Quitline
has shown that at 3 month follow up patients rando-
mised to the referral intervention had a higher rate of
sustained abstinence (12.3% compared with 6.9%). At 12
month follow-up patients in the referral intervention
had a higher rate of sustained abstinence (6.5% com-
pared to 2.6%), however this did not reach statistical sig-
nificance [16]. The researchers concluded that GPs
referring smokers to an evidence based telephone cessa-
tion service can result in increased cessation.
Practice nurses and cessation support
An innovative model for enhanced smoking cessation
support is provision of advice in the practice by general
practice nurses. Practice nursing is rapidly emerging in
Australia and is making a considerable contribution to
capacity in primary care [17].
In Australia the practice nurse workforce has grown
rapidly since 2003. Almost 60% of Australian general
practices now employing a practice nurse [18] and prac-
tice nurses are increasingly regarded as core members of
general practice teams [19]. The Australian Government
has committed over $A230 million to support practices
to employ practice nurses, however, their potential
impact has been constrained by poor role descriptions,
inadequate funding models, negative GP attitudes and
unclear legal implications of the nursing role [20].
Although consumers support the practice nurse role
in principle, there is no research to date on consumer
acceptability of specific practice nurse interventions
[21]. There is also a need for trials to test the impact of
practice nurse interventions to ensure that the signifi-
cant investment being made in expanding the practice
nurse workforce achieves maximum impact on improv-
ing quality of care and patient outcomes [22]. Face-to-
face support for smoking cessation provided within the
practice primarily by a trained practice nurse may
appeal to different groups of smokers who are less likely
to use a telephone service such as people from culturally
and linguistically diverse backgrounds (CALD). Support
in the practice has the potential to be even more effec-
tive than referral to an outside service, given the familiar
environment and setting of the practice within the local
community [9].
Several studies have explored the effectiveness of
involving the practice nurse in supporting smokers to
quit [23-31]. In a study by Vetter et al there was a
significant benefit at six month follow up [26];
another study demonstrated a significant reduction in
smoking status [29] and a third study showed a
reduction in the number of cigarettes smoked per day
[28]. All other studies showed no significant differ-
ence. Limitations of these studies included the low
uptake of the nursing intervention [23], research
designs that provided only a one off nurse consulta-
tion and a lack of follow-up [24]. Additionally, there
were low retention rates amongst smokers in these
studies. The difficulties in retention of this group as
study participants may have been responsible for the
small effect sizes and lack of significance seen in
some studies [32].
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Cost effectiveness of smoking cessation interventions
Smoking cessation strategies have been shown to be
highly cost effective compared to many pharmacological,
surgical and hospital treatments or services [33]. A
recent systematic review of studies in a range of settings
adjusted for variation in program effects and costing
methods found cost effectiveness ratios ranged from US
$490 to $US15280 per life-years saved (LYS) in different
settings [34].
Face to face interventions are the most common stra-
tegies. A recent review of cost effectiveness studies for
such face to face health behaviour interventions addres-
sing smoking cessation found favourable cost effective-
ness ratios for smoking cessation programs compared to
preventative pharmaceutical and invasive interventions
[35].
More intensive interventions may be more effective
but also more costly [10]. Many studies omit disadvan-
taged populations which are known to have higher levels
of smoking [10]. Health gains are likely to be larger in
such groups. Hence it is proposed that although more
intensive interventions may be more costly, cost effec-
tiveness will still be very favourable as a result of the
high health gains. The cost effectiveness analysis in this
study will compare the more intensive interventions to
usual care.
Aims and objectives
This study will test the uptake and effectiveness of
enhanced in-practice support for smoking cessation.
The in-practice intervention (Quit with Practice
Nurse) involves flexible support for quitting provided
primarily by the practice nurse in partnership with the
patient’s GP and the Quitline. The number and diversity
of smokers receiving intensive intervention will be opti-
mised by offering a flexible package of support from the
nurse, GP and Quitline to match the patient’s needs.
The rationale is that delivering more integrated and
intensive quitting support will be more effective and
offering flexibility in service provision will reach more
smokers from a wider range of demographic, socioeco-
nomic and cultural backgrounds.
The impact of the ‘Quit with Practice Nurse’ inter-
vention will be compared contrasted with an alterna-
tive intervention group as well as with a control
group. The alternative intervention is referral to an
evidence based telephone support service (Quitline
Referral Intervention). The control group is usual care
by the GP (control group). Referral to a specialized
cessation service such as the Quitline represents the
major alternative approach to supporting cessation.
An important strength of this study is the comparison
of the new approach to both a referral model and
usual care.
Specifically the study will
• Evaluate uptake of the ‘Quit with Practice Nurse’
intervention versus the referral intervention and the
control group in terms of the number of patients, demo-
graphics, socio-economic status, language and ethnicity,
smoking history and level of nicotine dependence.
Hypothesis: the ‘Quit with Practice Nurse’ intervention
will reach more smokers because it will meet the needs
of a greater range of smokers with different demographic,
socioeconomic and cultural characteristics than referral
model or standard in-practice GP management.
• Compare the effect on cessation of ‘Quit with Prac-
tice Nurse’ versus ‘Quitline Referral’ and the control
group. Hypothesis: the ‘Quit with Practice Nurse’ model
will achieve higher quit rates as more patients will
receive a cessation intervention that meets their indivi-
dual needs.
• Examine the cost effectiveness of the three
approaches and their components from the perspective
of the health care sector. Hypothesis: the more intensive
intervention may be more costly than usual care or
‘Quitline Referral’ but any higher costs of the ‘Quit with
Practice Nurse’ intervention will be justified by its higher
uptake and quit rate.
• Assess the acceptability to patients of the ‘Quit with
Practice Nurse’ intervention. Hypothesis: the ‘Quit with
Practice Nurse’ intervention will be acceptable to
patients as it offers a flexible package of support to meet
patient needs.
• Assess acceptability and sustainability of practice
nurse assisted support to quit from the perspective of
practice nurses and GPs. Hypothesis: the ‘Quit with
Practice Nurse’ intervention will be acceptable to prac-
tice nurses and GPs as it provides an important new role
for practice nurses and provides GPs the option of refer-
ral within their practice.
Methods/Design
This study is a three arm cluster randomised trial invol-
ving general practices with practice nurses located in
Sydney and Melbourne, which are Australia’s two largest
cities. Recruitment will expand if necessary to other
parts of New South Wales and Victoria. Practices will
be allocated to one of three groups 1) Quit with Practice
Nurse 2) Quitline Referral 3) usual care control group.
Recruitment
General practice recruitment
Practices which employ at least one practice nurse will
be eligible to participate. Eligible practices will be identi-
fied with the assistance of local general practice net-
works (local GP organisations). All GPs working in
these practices will be approached by mailing an initial
invitation letter followed by a telephone call from one of
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the chief investigators. GPs expressing interest on the
phone will be visited by project staff to explain the pro-
ject to GPs and practice nurses and to gain informed
consent.
Randomisation to intervention groups will follow pro-
cedures outlined in the CONSORT statement [36] and
will be performed by a researcher independent of the
project team. Randomisation will occur in permuted
blocks of size three using a system of sealed envelopes.
Following randomisation, practices are notified of their
allocation prior to the commencement of patient
recruitment. Practices in the control group are given
copies of smoking cessation guidelines [11]. Practices in
the active referral arm are in addition given copies of
active referral sheets with which to make referrals to the
Quitline. Practices in the ‘Quit with Practice Nurse’
group are scheduled for the practice nurse to attend the
one day training course (see below).
Patient recruitment
Eligible patients are those aged 18 and over presenting
to their GPs who are daily or weekly smokers. Potential
participants will be excluded if they meet any of the fol-
lowing criteria: unable to give informed consent (poor
physical and/or cognitive state), insufficient command of
English to comprehend the consent process and/or data
collection questions. A research assistant will be
attached to each participating practice for a two week
recruitment period and approach patients in the waiting
room prior to the consultation with the GP. Initially the
research assistant will assess patient eligibility and, if eli-
gible, patients will be given a copy of participant infor-
mation statement. Patients providing a written consent
will be asked to complete the baseline data question-
naire at this time. Patients take notice of their participa-
tion into the GP consultation. GPs respond to this
notification depending on their group allocation.
This method of recruitment maintains a separation of
baseline data collection from the intervention. Waiting
room recruitment has previously been used successfully
by members of the research team in studies on smokers,
[37,38] risky drinkers [39] and overweight and obese
patients [40].
Intervention
Quit with Practice Nurse
This intervention involves the practice nurse, GP and
Quitline working in partnership with the patient to pro-
vide flexible assistance that meets the needs of indivi-
dual smokers. The GP identifies smokers and their
willingness to quit and offers brief advice. Patients with
any interest in quitting are referred to the practice
nurse. The practice nurses will see the patient for an
initial assessment visit. At this assessment the practice
nurse gathers information about patient demographics,
smoking behaviour, stage of readiness to quit, previous
quit attempts, nicotine dependence (using Fagerstrom
test), previous use of pharmacotherapy and perceived
barriers to quitting. Patients are assisted to develop a
quit plan and (in consultation with the GP) encouraged
to use pharmacotherapy according to recommendations
in clinical practice guidelines [11,41]. Patients are then
offered a flexible package of ongoing support. Those
able to attend for face-to-face counseling are offered a
series of weekly (three follow-up visits) visits with the
practice nurse. At these visits patients are provided
behavioural counseling, support in use of pharmacother-
apy, relapse prevention advice and encouragement of
social support as shown in table 1.
Patients in this group who are unable to attend for
face-to-face consultations or who prefer telephone coun-
seling to support their quit attempts will be referred to
the Quitline using a faxed referral system. As in the refer-
ral intervention described below, patients are contacted
and offered services to meet their needs. Patients are
encouraged to use the proactive callback service which
has been shown to be more effective than reactive coun-
seling [42]. Feedback is provided by the Quitline to the
practice on acceptance, use and outcomes of services
offered to facilitate the ongoing management of the
patient in the practice. Patients who are able to attend
one or two practice nurse visits will be offered a combi-
nation of nurse counseling and referral to Quitline.
Nurse training for ‘Quit with Practice Nurse’ intervention
Training for the practice nurses will consist of a one day
training workshop where the nurses are educated in:
5As approach to smoking cessation counseling (Ask,
Assess, Advise, Assist, Arrange follow-up); basics of
motivational interviewing; nicotine dependence; smoking
cessation pharmacotherapy and resources for smoking
cessation including Quitline services. The practice
nurses will receive mentoring over the course of the
project from an experienced Quitline counselor who
they can contact for advice. The counselors involved
will attend the practice nurse training sessions to estab-
lish this mentoring relationship
Table 1 Practice Nurse Visits
Visit 1 Visit 2 Visit 3 Visit 4
Smoking assessment ✓
Nicotine dependence assessment ✓
Pharmacotherapy
discussed
✓ ✓ ✓ ✓
Nicotine patches offered to
eligible patients
✓ ✓ ✓
Quit support plan developed ✓
Cessation counseling support ✓ ✓ ✓ ✓
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Active referral to Quitline
The ‘Quitline Referral’ intervention involves the GPs
identifying smokers and their willingness to quit and
offering brief advice. Patients with any interest in quit-
ting are offered referral to the Quitline. Patients who
consent will have their referral faxed to the Quitline and
are provided with a brochure on Quitline services.
Patients are telephoned by the Quitline and offered ser-
vices to meet their needs. Patients who express interest
in quitting are offered a series of proactive callback
counseling/advice sessions [42]. Referring practices are
provided with feedback from the Quitline on accep-
tance, use and outcomes of services offered to facilitate
ongoing management of the patient. GPs are expected
to provide advice on use of medications and prescrip-
tions where appropriate.
Control Group
The control group involves GPs identifying smokers and
their willingness to quit and offering assistance in
accordance with their usual practice. This should
include advice on use of medications to quit and pre-
scriptions where appropriate. It may involve advice pro-
vided by themselves within the practice or referral to
the Quitline or both where the GP deems it appropri-
ate, but no provision is made to facilitate either. Based
on previous work, levels of either referral or intense
counseling within practice interventions are likely to be
very low [16].
Smoking cessation pharmacotherapy
Patients in all three groups will be encouraged to use
smoking cessation pharmacotherapy based on best prac-
tice guidelines [11,41]. For patients in all three groups
who are on low incomes and therefore eligible for subsi-
dised medicines under the Australian Government Phar-
maceutical Benefit Scheme (PBS) the project will fund
access to nicotine patches. This targeted subsidy will
not disrupt the ecological validity of the study as a test
of the different modes of cessation support as it will be
offered equally across all three arms of the study
Outcome measures
Patient level measures will be assessed at baseline, three
months and 12 months (the schedule of data collection
is shown in table 2. At baseline patients will be asked to
complete a paper questionnaire assessing demographics
including age, sex, language spoken at home, ethnicity,
education levels, occupation, current level of smoking,
nicotine dependence, quitting history and presence of
co-morbidities. Three month and 12 month data will be
collected by Computer Assisted Telephone Interview
(CATI) by trained interviewers who are blind to inter-
vention group until after the outcome data is collected.
Primary outcomes
Uptake of the intervention in each group and character-
istics of patients - age, sex, language spoken at home,
ethnicity, education levels, occupation, smoking history,
level of smoking and nicotine dependence.
Smoking cessation rates: sustained abstinence defined
as patients reporting abstinence of ≥ one month at the
three month follow-up and ≥ 10 months at the 12
month follow-up; and point prevalence abstinence
defined as ≥ seven days of sustained abstinence at the
three month and 12 month follow-up points. Validation
of smoking cessation will not be undertaken as reviews
confirm the accuracy of self-report measures, and con-
clude that validation is unnecessary in trials where there
is no strong association between the interviewer and
respondent [43]. Number and duration of quit attempts
will be a further outcome measure as it is known that
the key effect of advice from a health professional is to
encourage the smoker to try to quit [10,11].
Health economic outcomes: the economic evaluation
will compare the flexible support intervention ‘Quit with
Practice Nurse’ and the ‘Quitline referral intervention’
with standard ‘in practice management by the GP’ (con-
trol group.) Cost analysis will be from the perspective of
the health care sector and include direct costs of the
intervention, including for recruitment, and for the
intervention (GP costs, practice nurse costs, nurse train-
ing costs, telephone counseling costs, pharmaceutical
costs, and overheads such as room rents).
Process outcomes
Quantitative and qualitative data on process outcomes
will be collected as part of the CATI of participating
patients in each of the three arms at the three month
follow-up point. These questions will be asked only after
the primary outcome data on abstinence has been col-
lected. In the CATI patients in all three arms will be
asked about uptake including barriers and enablers to
uptake, extent and nature of the intervention received
including use of smoking cessation pharmacotherapy
(type of pharmacotherapy used and duration of use),
acceptability and perceived value of the smoking cessa-
tion support received. The interviews will also explore
patient perception on the influence of culture, language
and socioeconomic status on the acceptability of the
intervention approaches. Patients in the ‘Quit with Prac-
tice Nurse’ arm will be asked further questions about
the perceived value of the flexible approach to cessation
support. These will include their level of awareness or
lack of awareness of the flexibility, its importance or
otherwise for them, the important factors in the choices
made about support options, and their perception on
the roles of the providers involved (practice nurse, GP
and Quitline counselor).
The acceptability and sustainability of the ‘Quit with
Practice Nurse’ intervention will be evaluated with semi-
structured interviews with participating practice nurses,
GPs and Quitline counselors.
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Data Analysis
Analysis for the primary outcomes of sustained absti-
nence and point prevalence abstinence will be on an
intention to treat basis with cases retained regardless of
whether they accept or receive the intended interven-
tion. A series of planned imputation strategies for miss-
ing data will be used in examining outcomes for missing
data. These are 1) analysis will be done on all participat-
ing patients, where all patients with missing outcome
data will be assumed to be smokers; 2) the last known
value carried forward to replace the missing value; 3) an
analysis of outcomes for patients with complete out-
come data. We will compare cessation outcomes
between the three arms at three months and 12 month
follow-up using multiple logistic regression. This
approach will allow us to adjust for clustering and to
assess the effect of potential confounders such as age,
sex, socioeconomic status, ethnicity, language spoken at
home and nicotine dependence on cessation outcomes.
Health economic analysis
The study will estimate incremental cost effectiveness
ratios (ICER) of cost per quitter for brief advice and
referral to Quitline, and with the flexible support inter-
vention, compared to standard GP care. The ICER will
be estimated for the 12 month quit rate for the inter-
vention, less an unaided/natural quit rate. Adjustments
to effect sizes will also be made for long term relapse
rate among the 12 month quitters.
Analysis of qualitative data on process outcomes
Analysis will be based on thematic analysis. Our aim is
to identify common themes and issues about barriers
and facilitators to the uptake of the intervention from
the perspective of both patients and providers. This will
allow a richer understanding of the experiences of parti-
cipants in the study and maximise our capacity to pro-
vide meaningful answers to our research questions [44].
Sample size
The observed 12 month sustained abstinence outcomes
of GP usual care and Quitline referral in Borland et al.’s
study in Victoria were 2.6% and 6.5% respectively [16].
The sustained abstinence at six months in a pilot study
of practice nurse support was 16%. Assuming this drops
to 12% at 12 months we have calculated power to detect
a 5.5% difference in sustained abstinence quit rates
between ‘Quit with Practice Nurse’ intervention versus
the referral intervention and a 9.4% difference between
‘Quit with Practice Nurse’ intervention and the usual
care control group at one year follow up with 80%
power at the 5% significance level. Before adjustment for
clustering this requires 471 patients per group to detect
the 5.5% difference and 140 per group to detect the
9.4% difference (calculations using STATA software). To
adjust for clustering the intracluster correlation coeffi-
cient observed by Lennox et al. in a smoking cessation
trial in general practice has been used. The intracluster
correlation coefficient observed in this study was 0.013
[45]. The resulting design effect = [1+ (size of cluster-1)
× intracluster correlation]. In this study we plan to
recruit 25 patients per practice so the design effect is
1.31 so the number per arm is 471 × 1.31 = 617 giving
a total sample size of 1851. To enroll these participants
we will recruit 90 general practices and 2250 patients
across New South Wales and Victorian study locations
(to allow for approximately 10% drop out rate of prac-
tices) and randomise 30 practices to each arm of the
study.
Ethics Approval
The study has received ethics approval from the Univer-
sity of New South Wales, University of Melbourne and
University of Western Sydney Human Research Ethics
Committees.
Trial Registration
Australian New Zealand Clinical Trials Registry
(ANZCTR). Number: ACTRN12609001040257.
Discussion
This project will test an approach to supporting smok-
ing cessation in general practice based on partnership
between the practice nurse, GP and patient to support
quitting. This is a new approach in Australia which has
not had a system to provide face to face quitting sup-
port from specifically trained health professionals in a
Table 2 Schedule of data collection
At recruitment 3-months 12-months
Age, gender, language spoken at home, X
Smoking history X X X
Nicotine dependence X X X
Sustained abstinence X X
Point prevalence abstinence X X
Quit attempts X
Intervention costs X X
Process evaluation data from patients
Process evaluation data from PN, GPs and Quitline counselors X
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way that is accessible for most of the population. If suc-
cessful it would have major benefits for addressing
smoking which remains Australia’s most important
cause of preventable death and disease. The project is
highly relevant with current policy direction in develop-
ing practice nurse roles and expanding access to Medi-
care rebates for services provided by practice nurses.
Trials of actual interventions involving practice nurses
have been identified as an important step in advancing
the practice nurse role [22] and this study will provide
key evidence to inform this development.
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